Incidence of Sinusoidal Obstruction Syndrome Following Mylotarg (Gemtuzumab Ozogamicin, GO): a Prospective Observational Study in Routine Clinical Practice.

Autor: Tallman, Marti n S, McDonald, George B *, DeLeve, Laurie D *, Obi-Tabot, Eliot *, Kollmer, Carl *, Feingold, Jay M
Zdroj: In Blood 16 November 2008 112(11):956-956
Databáze: ScienceDirect